company background image
000504 logo

Landfar Bio-medicine SZSE:000504 Stock Report

Last Price

CN¥6.98

Market Cap

CN¥2.3b

7D

1.2%

1Y

-40.0%

Updated

06 Jul, 2024

Data

Company Financials

Landfar Bio-medicine Co., Ltd

SZSE:000504 Stock Report

Market Cap: CN¥2.3b

000504 Stock Overview

Operates as a biomedical technology company.

000504 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Landfar Bio-medicine Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Landfar Bio-medicine
Historical stock prices
Current Share PriceCN¥6.98
52 Week HighCN¥12.37
52 Week LowCN¥5.26
Beta0.69
11 Month Change14.99%
3 Month Change-16.61%
1 Year Change-40.03%
33 Year Change-65.26%
5 Year Change-36.66%
Change since IPO264.45%

Recent News & Updates

Risks Still Elevated At These Prices As Landfar Bio-medicine Co., Ltd (SZSE:000504) Shares Dive 31%

Jun 09
Risks Still Elevated At These Prices As Landfar Bio-medicine Co., Ltd (SZSE:000504) Shares Dive 31%

Landfar Bio-medicine Co., Ltd's (SZSE:000504) Popularity With Investors Under Threat As Stock Sinks 32%

Apr 17
Landfar Bio-medicine Co., Ltd's (SZSE:000504) Popularity With Investors Under Threat As Stock Sinks 32%

Recent updates

Risks Still Elevated At These Prices As Landfar Bio-medicine Co., Ltd (SZSE:000504) Shares Dive 31%

Jun 09
Risks Still Elevated At These Prices As Landfar Bio-medicine Co., Ltd (SZSE:000504) Shares Dive 31%

Landfar Bio-medicine Co., Ltd's (SZSE:000504) Popularity With Investors Under Threat As Stock Sinks 32%

Apr 17
Landfar Bio-medicine Co., Ltd's (SZSE:000504) Popularity With Investors Under Threat As Stock Sinks 32%

Landfar Bio-medicine Co., Ltd (SZSE:000504) Investors Are Less Pessimistic Than Expected

Mar 01
Landfar Bio-medicine Co., Ltd (SZSE:000504) Investors Are Less Pessimistic Than Expected

Shareholder Returns

000504CN BiotechsCN Market
7D1.2%-0.7%-1.4%
1Y-40.0%-22.5%-18.4%

Return vs Industry: 000504 underperformed the CN Biotechs industry which returned -22.5% over the past year.

Return vs Market: 000504 underperformed the CN Market which returned -18.4% over the past year.

Price Volatility

Is 000504's price volatile compared to industry and market?
000504 volatility
000504 Average Weekly Movement12.1%
Biotechs Industry Average Movement6.5%
Market Average Movement6.6%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 000504's share price has been volatile over the past 3 months.

Volatility Over Time: 000504's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
1991512Changqiao Youwww.landfar.cn

Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. The company operates through Biomedicine, and Energy Saving and Environmental Protection segments. The Biomedicine segment engages in the provision of stem cell storage and technical services; stem cell therapy research; medical device procurement and sales, etc. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business.

Landfar Bio-medicine Co., Ltd Fundamentals Summary

How do Landfar Bio-medicine's earnings and revenue compare to its market cap?
000504 fundamental statistics
Market capCN¥2.30b
Earnings (TTM)-CN¥28.97m
Revenue (TTM)CN¥128.03m

18.0x

P/S Ratio

-79.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000504 income statement (TTM)
RevenueCN¥128.03m
Cost of RevenueCN¥43.18m
Gross ProfitCN¥84.84m
Other ExpensesCN¥113.81m
Earnings-CN¥28.97m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 31, 2024

Earnings per share (EPS)-0.088
Gross Margin66.27%
Net Profit Margin-22.63%
Debt/Equity Ratio11.5%

How did 000504 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.